Symposium Program

ISLH 2025 Educational Content

Educational Program

The ISLH Annual Meeting is a 3 day conference preceded by a one-day educational workshop.
  Tue - May 06      Wed - May 07      Thu - May 08      Fri - May 09   


Wednesday, May 7th

8:00 - 9:30 AM
PLENARY SESSION: OPENING PLENARY
Chair/Organizer: John Frater, Katrien Devreese
Hall C1

8:00
New Directions in Anticoagulant Therapy
Jeffrey Weitz. Professor of Medicine a Biochemistry, McMaster University

8:30
Pediatric Myeloid Malignancies
Jeffery Klco. St Jude Children's Research Hospital

9:00
Equity Issues in Lab Testing
Madeleine Verhovsek. McMaster University
9:30 - 10:00 AM
BREAK: COFFEE BREAK / EXHIBITS
Ballroom
10:00 - 11:30 AM
CONCURRENT SESSION: CONCURRENT 1: THROMBOPHILIA
Chair/Organizer: Marian Rollins-Raval, Chee Wee Tan
Hall C1

10:00
Lupus Anticoagulant Testing in Challenging Situations
Katrien Devreese. Ghent University Hospital, Ghent University

10:30
Genetic Testing vs Functional Testing to Diagnose Thrombophilia
Juliana Perez Botero. Mayo Clinic

11:00
Novel Anticoagulants (XI and XII Targets)
Jean Connors. Brigham and Women's Hospital/Harvard Medical School

CONCURRENT SESSION: CONCURRENT 2: FLOW CYTOMETRY: LEUKEMIA IMMUNOPHENOTYPING
Chair/Organizer: Alexa Siddon, Swati Pai
Hall C4

10:00
Implementation of TRBC1 in the Assessment of T-cells by Flow Cytometry
Katherine Devitt. University of Vermont Medical Center

10:30
Advances in Flow Cytometry for Mixed Phenotype and Ambiguous Leukemias
Olga Weinberg. UT Southwestern Medical Center

11:00
Immunophenotyping of Hematopoietic Cell Populations: CLSI H62 Instrument Qualification, Setup, and Standardization
Amr Rajab. LifeLabs Medical Laboratory Services
12:00 - 1:00 PM
CORPORATE WORKSHOP: CORPORATE LUNCH WORKSHOP - SCOPIO LABS
Hall C3

The Biggest Breakthrough Since the CBC Analyzer? The Evolving Journey from State-of-the-Art Digital Imaging and AI-Driven Decision Support to the Imminent Reality of Fully Automated Peripheral Blood Smear Review
What if we could confidently leave every routine peripheral bloo. (show more)



CORPORATE WORKSHOP: CORPORATE LUNCH WORKSHOP - SYSMEX
Hall C4

Digital Morphology: A Laboratory Tool with Clinical Impact
The presentation will discuss how implementation of digital cell morphology improved efficiency and connectivity in the Hematology Laboratory at Mersey and West Lancashire Teaching Hospitals NHS Trust in the UK. Educati. (show more)


1:30 - 3:00 PM
PLENARY SESSION: PRESIDENTIAL SYMPOSIUM
Chair/Organizer: John Frater, Katrien Devreese
Hall C1

1:30
Berend Houwen Lecture: Systemic Mastocytosis
Tracy George. University of Utah/ARUP Laboratories

2:15
Wallace H. Coulter Lecture: Making Molecular Diagnostics Faster.
Carl Wittwer. University of Utah / Crestwood Technology
3:00 - 3:45 PM
BREAK: COFFEE BREAK / EXHIBITS
Ballroom
3:45 - 5:15 PM
CONCURRENT SESSION: CONCURRENT 3: MOLECULAR DIAGNOSIS IN RED BLOOD CELL DISORDERS: WHEN AND HOW
Chair/Organizer: Sarah Patterson, Samia Rizk
Hall C1

3:45
Role of Third Generation Sequencing in Screening and Diagnosing Hemoglobinopathies
Landry Nfonsam. Molecular Genetics Laboratory, Hamilton Regional Laboratory Medicine Program, Hamilton Health Sciences, Hamilton, Ontario, Canada | Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada

4:15
Handling Common Diagnostic Dilemmas in Hemoglobinopathy Testing
Archana Agarwal. University of Utah/ARUP Laboratories

4:45
Genetic Testing in Sickle Cell Disease: From Newborn Screening to Applications for Transfusion Care
Yves Pastore. CHU Ste-Justine

CONCURRENT SESSION: CONCURRENT 4: MOLECULAR TESTING IN LYMPHOID DISEASE
Chair/Organizer: Alexa Siddon, Jin-Yeong Han
Hall C4

3:45
ISCN 2024 Nomenclature for Optical Genome Mapping
Jean McGowan-Jordan. Children's Hospital of Eastern Ontario/University of Ottawa

4:15
IGHV Somatic Hypermutation Testing in Chronic Lymphocytic Leukemia: Current Practices, Challenges, and Future Directions
Tanya Gillan. Nova Scotia Health/Dalhousie University

4:45
Diagnosis of Hereditary Hematologic Malignancies
Amy Trottier. Nova Scotia Health
5:15 - 6:45 PM
POSTER: WELCOME RECEPTION / POSTER SESSION I / EXHIBITS
Ballroom

101
MYELODYSPLASTIC NEOPLASM SCORING FLAG, AN EARLY CLINICAL INDICATOR EVALUATED IN CYTOPENIC PATIENTS USING HORIBA HEMATOLOGY ANALYZER YUMIZEN H2500.
Julie BLANCHI1, Sebastien RAIMBAULT2, Benoit RUCHETON1, Marion EVEILLARD3FranAsoise DURRIEU1. 1Institut BergoniAc, Bordeaux, France.2HORIBA ABX SAS, Grabels, France.3University Hospital, Nantes, France

103
Evaluation of MiSelect R System: A Comparison with Flow Cytometry and/or RT-qPCR Assays for Measurable Residual Disease Monitoring in Acute Myeloid Leukemia
Ying-Jung Huang1Ju-Yu Tseng2, Ming-Chung Kuo1, 3, Yuen-Chin Wang1, Hsuan-Jen Shih1, Yu-Chieh Tung1, Lee-Yung Shih1, 3. 1Division of Hematology-Oncology, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan.2MiCareo Taiwan Co. Ltd., Taipei, Taiwan.3College of Medicine, Chang Gung University, Taoyuan, Taiwan

105
Performance Evaluation of the PBIA-100A Digital Morphology Analyzer for Platelet Counting
Seon Joo Kang, Soyeon Kim, Jeehey Kim, Jin Young Lee, Hee Joo Lee. SD Medical Research Institute, Yongin, South Korea

107
MONOCYTE DISTRIBUTION WIDTH VARIATIONS AND INFLAMMATORY RESPONSE INDUCED BY GRAM-NEGATIVE AND GRAM-POSITIVE LIVE BACTERIA AND THEIR ENDOTOXINS
D. Ligi1, C. Della Franca1, F. Salvatori1, S. Ranieri Chiatamone2, G. Brandi3, GF Schiavano4E. Sukhacheva5, F. Mannello1. 1Department of Biomolecular Sciences, Section of Biochemistry and Biotechnology, University of Urbino Carlo Bo, Urbino, Italy.2Operative Unit of Clinical Pathology and Microbiology, Department of Services Teramo, Italy.3Department of Biomolecular Sciences, Section of Pharmacology and Hygiene, University of Urbino Carlo Bo, Urbino, Italy.4Department of Humanities, University of Urbino Carlo Bo, Urbino, Italy.5Beckman Coulter Eurocenter, Nyon, Switzerland

109
The potential utility of extended white blood cell parameters and cell population data in respiratory tract infection diagnosis
Tandry Meriyanti1, 2, Chaterine Elisabeth1. 1Siloam Hospitals Lippo Village, Banten, Indonesia.2Pelita Harapan Univerisity, Banten, Indonesia

111
Longitudinal Evaluation of Hematological Values obtained with Reference Automated Hematology Analyzers of Six Manufacturers (2024) - On behalf of The Japanese Society for Laboratory Hematology Standardization Committee (JSLH-SC) -
Yutaka Nagai1, 2, Tomohiro Takeda1, Kazuto Tsuruda3, Hiromichi Matsushita2, Tohru Inaba4, Yukako Koike5, Toshiyuki Ikemoto6, Masahiro Jona7, Shin-ichi Fujimaki8, Yoko Yatabe9, Chiaki Ikeda10, Sayaka Mori3, Kazue Yoshitomi11, Ayako Maki12, Kei Shimbo13, Akiyoshi Takami14. 1Kansai University of Health Sciences, Osaka, Japan.2Keio University School of Medicine, Tokyo, Japan.3Nagasaki University Hospital, Nagasaki, Japan.4Kyoto Prefectural University of Medicine, Kyoto, Japan.5Toranomon Hospital, Tokyo, Japan.6Shiga University of Medical Science Hospital, Otsu, Japan.7The University of Tokyo Hospital, Tokyo, Japan.8International University of Health and Welfare, Tochigi, Japan.9Keio University Hospital, Tokyo, Japan.10National Cancer Center Hospital, Tokyo, Japan.11Kindai University Hospital, Osakasayama, Japan.12Osaka Medical and Pharmaceutical University Hospital, Osaka, Japan.13Dokkyo Medical University Hospital, Tochigi, Japan.14Aichi Medical University, Nagakute, Japan

113
Analytical Validation of the iSED® automated analyzer for Erythrocyte Sedimentation Rate (ESR)
Joyce Richardson Etokwu, Lukas Graf, Miriam Herma-Looser, Susanne Lutz, Bernadette Landolt, Silke Langhof. Center for Laboratory Medicine, St. Gallen Switzerland

115
Ferritin and Other Laboratory Markers Elevation in Pregnant Patients with Combined COVID-19 and Preeclampsia Versus COVID-19 Alone
Dhruv Shah1, Georgiana Nemeti2, 3, Gheorghe Cruciat2, 3, Daniel Muresan2, 3, Chaikh-Sulaiman Mariam-Suzana3, A. Kinga Malinowski4, 5, Rezan Abdul-Kadir6, 7, Maha Othman1, 8, 9 . 1Department of Biomedical and Molecular Medicine, Queen's University, Kingston, ON, Canada.2Obstetrics and Gynaecology I, Mother and Child Department, University of Medicine and Pharmacy of Cluj-Napoca, Cluj-Napoca, Rumania.3Obstetrics and Gynaecology I, County Emergency Hospital Cluj-Napoca, Cluj-Napoca, Rumania.4Department of Obstetrics and Gynaecology, University of Toronto, Toronto, ON, Canada.5Division of Maternal-Fetal Medicine, Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada.6Department of Obstetrics and Gynaecology, The Royal Free National Health Service Foundation Hospital, London, United Kingdom.7Institute for Women's Health, University College London, London, United Kingdom.8School of Baccalaureate Nursing, St. Lawrence College, Kingston, ON, Canada.9Clinical Pathology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt

117
Evaluating Unghosted Cells (UGC): An Automated Blood Cell Counter-derived Novel Red Cell Research Parameter for its Clinical Utility and Diagnostic Implications Across a Spectrum of Pathological Conditions
Praveen Sharma1, Anita Giri1, Dikshat Gupta2, Minakshi Gupta1, Pulkit Rastogi1, Srinivasan Peyam1, Aashima Arora1, Alka Khadwal1, Elena Sukacheva3, Prashant Sharma1, Reena Das1. 1Postgraduate Institute of Medical Education and Research, Chandigarh, India.2The Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.3Beckman Coulter Eurocenter 22, Nyon, Switzerland

119
A novel method to detect platelet RNA content in platelets using a cell membrane-impermeable dye.
Tomohiro Takeda1, Hiromi Uekita1, Risa Hata1, Yutaka Nagai1, 2. 1Clinical Laboratory Science, Kansai University of Health Sciences, Osaka, Japan.2Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan

123
Generative AI Revolutionizes Hematology Analysis: Empowering Laboratory and Clinical Diagnostics
Yuting Wang1, Guoqing Zhu2, Liyan Cui3, Baohong Yue4, Zhizhi Liu1Bruce Qian1. 1Dymind Biotechnology Co., Ltd., Shenzhen, China.2Institute of Hematology a Blood Diseases Hospital, Tianjin, China.3Peking University Third Hospital, Beijing, China.4The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

125
Object detection model for quantifying fluorescence in situ hybridization (FISH) signal patterns in chronic lymphocytic leukemia (CLL)
Xinjie Xu1, Reid Meyer2, Christopher A Sattler2, Kassandra Fisch2, Ben Black3, Kim Olechovski3, Falon Markow3, Shane Swenson3, Rick Smith3, Jansen Seheult1. 1Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.2Division of Laboratory Genetics and Genomics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.3Techcyte, Inc., Orem, UT, USA

127
A Retrospective Study of Adult D-dimer Test Utilization
Hassan Abu Sabah1, 2, Rabab Al Dawood1, 3, Natalie Mathews1, 4, James Douketis5, Catherine Hayward1, 5. 1Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.2Department of Pathology and Laboratory Medicine, King Faisal Medical City for Southern Regions, Abha, Saudi Arabia.3Department of Pathology and Laboratory Medicine, King Fahad Specialist Hospital, Dammam, Saudi Arabia.4Hematology/Oncology, Centre Hospitalier Universitaire Sainte-Justine, MontrAcal, QC, Canada.5Department of Medicine, McMaster University, Hamilton, ON, Canada

129
Measurement of Direct Oral anticoagulant (DOAC) and Low Molecular Weight Heparin (LMWH) in plasma containing both, using DOAC-Stop™ and Hepzyme®. Can the use of DOAC-Stop™ and Hepzyme® establish baseline results in these samples.
Emma J Broomhead, Jackie Dobson-Storr, Lee J Beckett. Coagulation Department, Northern General Hospital Sheffield, United Kingdom

131
Nordic Biomarker MRX PT DOAC assay – A Comparative Study on Three Coagulation Analysers
Jackie Dobson-Storr1, Lee J Beckett1, Emma J Broomhead1, Mark Crowther2, 3, Brittany MA Slater2, Karen Moffatt2, 3, 4, Liselotte Onelov5. 1Coagulation Department, Northern General Hospital, Shefield, United Kingdom.2Department of Medicine, McMaster University, Hamilton, ON, Canada.3Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.4Hamilton Regional Laboratory Medicine Program, Hamilton, ON, Canada.5Nordic Biomarker, Umea, Sweden

133
Evaluation of the Lysis Timer in bleeding disorders of unknown cause
Eva Gijbels1, Katrien M.J. Devreese1, 2. 1Coagulation Laboratory, Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium.2Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium

135
Distribution Ranges of Apixaban Concentrations for Stroke Prevention in Korean Patients with Atrial Fibrillation
Jin-Yeong Han1, Suji Park1, Jae-Ryong Shim1, Kwang-Sook Woo1, Jong-Sung Park2. 1Department of Laboratory Medicine, Dong-A University College of Medicine, Busan, Korea.2Department of Cardiology, Dong-A University College of Medicine, Busan, Korea

137
Development of VerifyNow Quality Control Materials Reflecting Drug Responsiveness to P2Y12 Inhibitors and Aspirin
Taekyun Kim1, Miok Choi1, Mijeong Kim1, Miyoung Kim1, 2, Young-Uk Cho1, 2Seongsoo Jang1, 2. 1Department of Laboratory Medicine, Asan Medical Center, Seoul, South Korea.2Departments of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, South Korea

139
Evaluation of APTT mixing test interpretation methods: application of ICSH guidelines and comparison with routine practice
Young Kyung Lee1, 2, Youngmin Kim2Jeonghee Lee2. 1Department of Laboratory Medicine, Hallym University College of Medicine, Chuncheon, South Korea.2Department of Laboratory Medicine, Hallym University Sacred Heart Hospital, Anyang, South Korea

143
Performance of a Novel Bovine Chromogenic Factor VIII Assay in the Recovery of Factor VIII Replacement Therapies
Tara Quinton, Karen M. Black, Ali Sadeghi-Khomami. Precision BioLogic Inc., Dartmouth, NS, Canada

145
Data-Driven Establishment of Tube Fill Requirements for PT and PTT on the Automated CS-5100 Coagulation Analyzer
Julie R Schmidt, Juan J Sanchez Ramirez, Grace Thorsen, Anna E Merrill. University of Iowa Health Care, Iowa City, IA, USA

147
Clinical Profile of Rare Coagulation Factor Deficiencies in An Asian Population
Sim Leng Tien. Singapore General Hospital, Singapore, Singapore

149
Comparison between the Clauss Method and the Calculated Method for Fibrinogen Measurement
Paula Torralbo MartAsn, Victor GonzAilvez Agullo, Soledad GarcAsa Chileme, Lara Papay RamAsrez, Jose Vicente Garcia LarioTomas De Haro MuApoz. Hospital Universitario ClAsnico San Cecilio, Granada, Spain

151
Hematological biomarkers useful to monitor thrombotic risk in pregnant patients with Systemic Lupus Erythematosus
Rogelio Vega-Agavo1, Miguel A Alvarez-Guerrero2, Yesenia Ambriz-Murillo3, Nallely Garcia-Larragoiti1, Alan F Cano-Mendez1, Sofia Zavala-Guijosa1, Patricia Guzman-Cancino1Martha Eva Viveros-Sandoval1. 1Laboratorio de Hemostasia y Biologia Vascular UMSNH, Morelia, Mexico.2Servicio Reumatologia, Hospital General Dr Miguel Silva, Morelia, Mexico.3Servicio Reumatologia, Hospital de Alta Especialidad ISSSTE, Morelia, Mexico

153
Performance of different Flow Cytometry standardized protocols in detection of B-ALL Measurable Residual Disease
Laiz C Bento, Flavia A Sousa, Elizabeth X Souto, Nydia S Bacal. Hospital Israelita Albert Einstein - Citometria de Fluxo, SApo Paulo, Brazil

155
Monitoring Response to Therapy: Expanding marrow assessment beyond residual disease detection
Sarah Blain, Fangyan Dai, Chad Hudson, Fan-Chi Hsu, Ashley Eckel, Andrew Menssen, Benjamin Stueben, Laura Pardo, Loren Lott, Keely Ghirardelli, Denise Wells, Michael Loken. HematoLogics, Seattle, WA

157
A single-centre retrospective study investigating the utility and cost of early molecular testing in Monoclonal B-cell Lymphocytosis and Chronic Lymphocytic Leukemia in Southwestern Ontario
Ortenc Hoxha1, 2, Mrinal Lad3, Benjamin Hedley2, 3, Ian Chin-Yee1, 2, Cyrus Hsia1, 2, Benjamin Chin-Yee1, 2. 1Division of Hematology, Department of Medicine, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, Canada.2London Health Sciences Centre, London, ON, Canada.33Department of Pathology and Laboratory Medicine, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, Canada

159
Comparative analysis of RAS-associated autoimmune leukoproliferative disorder and RASopathy-associated transient myelomonocytic proliferations – expansion of immunophenotypic and molecular features
Rachel Mariani1, 2, Jennifer Mason1, Melissa Stalling3. 1Phoenix Children's Hospital, Division of Pathology and Laboratory Medicine, Phoenix, AZ, USA.2University of Arizona College of Medicine Phoenix, Phoenix, AZ, USA.3Akron Children's Hospital, Akron, OH, USA

161
A multicentre study to evaluate an in-house multiparameter immunophenotypic panel to identify precursor B-cells in the determination of measurable residual disease in paediatric B-cell acute lymphoblastic leukaemia
Zanre Nell1, Kennedy N. Otwombe2, Jennifer A. Geel3, Deborah K. Glencross1. 1Department of Haematology and Molecular Medicine, Charlotte Maxeke Johannesburg Academic Hospital, University of the Witwatersrand, Johannesburg South Africa.2Perinatal HIV Research Unit, Chris Hani Baragwanath Hospital, University of the Witwatersrand, Johannesburg South Africa.3Department of Paediatric Oncology, Charlotte Maxeke Johannesburg Academic Hospital, University of the Witwatersrand, Johannesburg South Africa

163
Diagnostic Potential of Q-flag and Q-frags in Beta Thalassemia: A Comparative Analysis with Nutritional Anemias
Muhammad Shariq Shaikh1, Joao Nunes2, Mari Kono2. 1Department of Pathology a Laboratory Medicine, Aga Khan University Hospital, Karachi, Pakistan.2R a D Centre, Sysmex Asia Pacific, Singapore, Singapore

165
Diagnosis of Hepatosplenic T Cell Lymphoma directed by Flow CytometryDiagnosis of Hepatosplenic T Cell Lymphoma directed by Flow Cytometry
Vanessa Afonso Silva, Daniel Silva Nogueira, Felipe Vieira Rodrigues Maciel, Juliana Carneiro Azevedo, MarAsal Cavalcante de Andrade Silva. University of SApo Paulo, SApo Paulo, Brazil

167
The mutational landscape of classical myeloproliferative neoplasms in the Western Cape Province South Africa
Zivanai C Chapanduka1, Marthinus J Dicks1, Ibtisam Abdullah1, 2, Carmen Swanepoel1, Erica-Mari Nell1. 1Stellenbosch University FMHS Division of Haematological Pathology, Cape Town, South Africa.2Division of Haematology Department of Pathology Health New Zealand Northern Region New Zealand, Northern Region, New Zealand

169
IRX1 silencing-mediated drug resistance pathway repression predicts adverse prognosis in FLT3 mutation acute myeloid leukemia
Yu Gu1, 2, 4, Jing-Dong Zhou1, 2, Zi-Jun Xu2, 3, Xiang-Mei Wen2, 3, Ting-Juan Zhang1, 2, Jiang Lin2, 3, Jun Qian1, 2. 1Department of Hematology, Affiliated People's Hospital of Jiangsu University, Zhenjiang, China.2Zhenjiang Clinical Research Center of Hematology, Zhenjiang, China.3Laboratory Center, Affiliated People's Hospital of Jiangsu University, Zhenjiang, China.4Department of Hematology and Hematological Laboratory Science, Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China

171
Next-Generation Strategies for Hemophilia A Diagnosis: Lessons learned from 518 Cases from North India
Manu Jamwal1, Ritika Sharma1, Hari Kishan Senee1, Narender Kumar1, Heera Singh1, Jasbir Kaur Hira1, Pramod Singh1, Chander Hans1, Deepak Bansal2, Amita Trehan2, Arihant Jain3, Pankaj Malhotra3, Jasmina Ahluwalia1, Reena Das1. 1Department of Hematology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.2Department of Pediatrics (Hematology-Oncology Unit), Postgraduate Institute of Medical Education and Research, Chandigarh, India.3 Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India

173
Platelet-VWF Interactions: A Novel Alternative Binding Site for GPIbαGOF on VWF
Thomas D. Kazmirchuk1, Calvin Bradbury-Jost1, Anastasiia Koziar1, Jiashu Wang1Maha Othman2, 3, 4, Ashkan Golshani1. 1Carleton University, Ottawa, ON, Canada.2Queen's University, Kingston, ON, Canada.3St. Lawrence College, Kingston, ON, Canada.4Mansoura University, Mansoura, Egypt

175
Tumor-Educated Platelets: Comparison of Platelet RNA Isolation Methods and the Impact of Storage Conditions on Biomarker Detection
In-Suk Kim1, Jeong Nyeo Lee2, Dong Uk Kim3. 1Department of Laboratory Medicine, Pusan National University School of Medicine, Pusan National University Yangsan Hospital, Yangsan, South Korea.2Department of Laboratory Medicine, Haeundae Paik Hospital, Inje University College of Medicine, Busan, South Korea.3Department of Internal Medicine, CHA Gumi Medical Center, CHA University School of Medicine, Gumi, South Korea

177
Optimization and proof-of-concept for Oxford Nanopore Technology long-read sequencing with PCR/capture-free adaptive sampling based enrichment in acute myeloid leukemia genomic profiling: a pilot study
Eric McGinnis1, 2, Zeid Hamadeh1, 2. 1Vancouver General Hospital, Department of Pathology and Laboratory Medicine, Vancouver, BC, Canada.2University of British Columbia, Department of Pathology and Laboratory Medicine, Vancouver, BC, Canada

179
Development of a simplified and high-sensitive CES assay panel for the genetic classification and risk-stratification in Acute Myeloid Leukemia
Yuki Namba, Mayu Ikeda, Rinko Sasaki, Ryotaro Miyamoto, Hikaru Hattori, Motonari Daitho. Sysmex Corporation, Kobe, Japan

183
Molecular Insights into High-Grade B-Cell Lymphomas: A Study from Pakistan
Muhammad Shariq Shaikh, Zeeshan Ansar Ahmed. Aga Khan University Hospital, Karachi, Pakistan

185
FOXP1 is associated with oncogenesis and clinical outcomes in hematologic malignancies
Xiang-mei Wen1, 2, 3, Zi-jun Xu1, 2, 3, Hao-xi Ni1, 2, 3, Su-wan Liu1, 2, 3, Ye Jin2, 4, Wei Zhao2, 4, Shu-yu Luo1, 2, 3, Yuan-yuan Fang1, 2, 3, Zhen-wei Mao2, Jiang Lin1, 2, 3, Jun Qian2, 4. 1Laboratory Center, Affiliated Peoplea, Zhenjiang, China.2Zhenjiang Clinical Research Center of Hematology, Affiliated Peoplea, Zhenjiang, China.3The Key Lab of Precision Diagnosis and Treatment in Hematologic Malignancies of Zhenjiang City, Affiliated Peoplea, Zhenjiang, China.4Department of Hematology, Affiliated Peoplea, Zhenjiang, China

189
A federated learning approach to generalize blood cell image classification models in multicenter settings
Kevin Barrera2, Natali Lorenzo2, Anna Merino1, JosAc Rodellar2. 1CORE Laboratory. Biochemistry and Molecular Genetics Department. Biomedical Diagnostic Center. Hospital Clinic, Barcelona, Spain.2Department of Mathematics. Technical University of Catalonia, Barcelona, Spain

191
A Preliminary Evaluation of a Model for Morphological Recognition of White Blood Cells in Peripheral Blood Smears Using Image Processing
Siew Lian Chong1, Asral Wirda Ahmad Asnawi2, Yuen Fen Tan4, 5, Veena Selvaratnam1, Sen Mui Tan1, Chee Onn Leong3. 1Hospital Ampang, Ampang, Selangor, Malaysia.2Sunway Medical Centre, Bandar Baru Sunway, Selangor, Malaysia.3AGTC Genomic Sdn Bhd, Bukit Jalil, Selangor, Malaysia.4Cytovision Sdn Bhd, Kuala Lumpur, Malaysia.5Center for Cancer Research, UTAR, Kajang, Selangor, Malaysia

193
UNRAVELING MONOCYTE AND NEUTROPHIL MORPHOLOGICAL ALTERATIONS IN SEPSIS CONDITION BY DIGITAL MORPHOLOGY AND TRANSMISSION ELECTRON MICROSCOPY
C. Della Franca1, S. Ranieri Chiatamone2, M. Battistelli3, F. Salvatori1, D. Ligi1E. Sukhacheva4, F. Mannello1. 1Department of Biomolecular Sciences, Section of Biochemistry and Biotechnology, University of Urbino Carlo Bo, Urbino, Italy.2Operative Unit of Clinical Pathology and Microbiology, Department of Services, qG. Mazziniq Hospital, ASL of Teramo, Teramo, Italy.3Department of Biomolecular Sciences, Section of Morphology, Physiology and Environmental Biology, University of Urbino Carlo Bo, Urbino, Italy.4Beckman Coulter Eurocenter, Nyon, Switzerland

197
Blister Cells in a Sickle Cell Disease Patient with Right Heart Failure, Hyperhemolysis, and Acute Chest Syndrome
Amarilis Figueiredo1, Rachelle Blackman1, 2, Kim Ingalls2, Allam Shawwa1, 2. 1Dalhousie University, Halifax, NS, Canada.2NS Health Authority, Halifax, NS, Canada

199
Assessment of ChatGPT analysis of hematopathology images
Matt LeRoux1, Elona Turley2, David Conrad1, 3, 4. 1Dalhousie University, Halifax, NS, Canada.2BC Children's Hospital, Vancouver, BC, Canada.3Nova Scotia Health, Halifax, NS, Canada.4IWK Health, Halifax, NS, Canada

201
An Unusual Case of Classic Hodgkin Lymphoma with Strong Expression of B-cell Markers
Christopher Liwski1, 2, David Conrad1, 2, 3, Allam Shawwa1, 2, Sorin Selegean1, 2. 1Dalhousie University, Halifax, NS, Canada.2Nova Scotia Health, Halifax, NS, Canada.3IWK Health, Halifax, NS, Canada

203
Discordant plasma cell counts between bone marrow biopsy and aspirate specimens
Ross Porter1, Pantelis Andreou1, David Conrad1, 2, 3. 1Dalhousie University, Halifax, NS, Canada.2IWK Health, Halifax, NS, Canada.3Nova Scotia Health, Halifax, NS, Canada

207
Learning from EQA: When is debris not debris?
Andrea Teuchert1, Bashori Rahman1, Barbara De la Salle1, Peter Carey2. 1UK NEQAS Haematology, Watford, United Kingdom.2The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle, United Kingdom

211
Multiple Myeloma Transformation to a Plasmablastic Phenotype: A Diagnostic Dilemma and Therapeutic Challenge
Sima Zolfaghari1, Donna Ledingham1, Ronald Angeles2, Muhammad Aslam2. 1Regina General Hospital, Regina, SK, Canada.2Pasqua Hospital, Regina, SK, Canada

215
Assessment of the Stability of Platelet Parameters in Different Anticoagulants Over Time
Rosana M Cosentino Penteado, Camila B Monteiro, Cristina M Ito, Glaucia S Gomes, Adriana N Gomes, Zuleide C Dias, Lilian D Reis, Andreza O Santos, Andrea A Rocco Villarinho, JoApo C Campos Guerra. Albert Einstein Hospital, SApo Paulo Brazil

217
Acquisition time for light transmission platelet aggregometry on an automated haemostasis analyser. On behalf of the Autoplate Study Group.
Sean Platton1, Fatimot Alaoye2, Peter Baker3, Sarah Harper3, Robert Jones4, Richard Kirby5, Stephen MacDonald6, Aine McCormick7, Danielle White6, Clare Wigley7, Nada Yartey8. 1Haemophilia Centre, Royal London Hospital, Barts Health NHS Trust, London United Kingdom.2Haematology Laboratory, Great Ormond Street Hospital for Children NHS Foundation Trust, London United Kingdom.3Oxford Haemophilia and Thrombosis Centre, Oxford University Hospitals NHS Foundation Trust, Oxford United Kingdom.4Department of Coagulation, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield United Kingdom.5Haemophilia Centre, Queena, Nottingham United Kingdom.6Department of Haematology, Specialist Haemostasis Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge United Kingdom.7Diagnostic Haemostasis and Thrombosis, St Thomasa, London United Kingdom.8National Health Service East and Southeast London Pathology Partnership, London United Kingdom

219
Influence of intra-cuvette stir-speed on light transmission platelet aggregometry on an automated haemostasis analyser. On behalf of the Autoplate Study Group.
Sean Platton1, Fatimot Alaoye2, Peter Baker3, Sarah Harper3, Robert Jones4, Richard Kirby5, Stephen MacDonald6, Aine McCormick7, Christopher Reilly-Stitt8, Danielle White6, Clare Wigley7, Nada Yartey9. 1Haemophilia Centre, Royal London Hospital, Barts Health NHS Trust, London United Kingdom.2Haematology Laboratory, Great Ormond Street Hospital for Children NHS Foundation Trust, London United Kingdom.3Oxford Haemophilia and Thrombosis Centre, Oxford University Hospitals NHS Foundation Trust, Oxford United Kingdom.4Department of Coagulation, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield United Kingdom.5Haemophilia Centre, Queena, Nottingham United Kingdom.6Department of Haematology, Specialist Haemostasis Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge United Kingdom.7Diagnostic Haemostasis and Thrombosis, St Thomasa, London United Kingdom.8United Kingdom National External Quality Assurance Scheme for Blood Coagulation, London United Kingdom.9National Health Service East and Southeast London Pathology Partnership, London United Kingdom

221
Prophylactic half- dose platelet transfusion effect on thrombocytopenia, transfusion, and bleeding occurrence
Majed Refaai, Christine Cahill, Hannah Spector, Madelyn Gatchell, Bianca Santonastaso. University of Rochester, Rochester, NY, USA

223
Silent platelet clumps? Evaluation of their impact to the platelet count
Lihjen Sun, Huguette Mulumba, Christine Rongey. Abbott, Santa Clara, CA, USA

225
From Bone Marrow to Blood: Macrocytic Hemolytic Anemia and Skewed Chimerism Reveal Reconstitution of β-Thalassemia 6 years Post-Hemopoietic Stem Cell Transplant
Fares Khaled AlFares1, 2, 3, David Conrad2, 3, 4, Bruce Crooks2, 3. 1Kuwait University Faculty of Medicine, Kuwait City, Kuwait.2Dalhousie University Faculty of Medicine, Halifax, NS, Canada.3IWK Health, Halifax, NS, Canada.4Nova Scotia Health, Halifax, NS, Canada

227
The Clinical Utility of ESR and CRP in Inflammation: Evidence from Literature and Guiding Effective Application
Mazen Assar1, 2Maha Othman2, 3, 4. 1Internal Medicine Department, University of British Columbia, Vancouver, BC, Canada.2Department of Biomedical and Molecular Sciences, School of Medicine, Queen's University, Kingston, ON, Canada.3School of Baccalaureate Nursing, St Lawrence College, Kingston, ON, Canada.4Faculty of Medicine, Mansoura University, Mansoura, Egypt

233
Evaluation of a New HbA1c Analyzer for Accurate HbA1c Measurement in Samples Containing Hemoglobin Variants
Yueying Huang1, Weijie Xie1, Anping Xu1, Ling Ji1Yan Liu2. 1Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen China.2Clinical Department (IVD), Shenzhen Mindray Bio-Medical Electronics Co., Ltd, Shenzhen China

235
A Family with a Rare Haemoglobin Variant (Hb Port Phillip)
Wei Lin Kwan, Zhao Qin Lim, Lai Ngah Leong, Noor Lydia Mohd Saleh, Soh Hong Ang, Joyce Ching Mei Lam. KK Women's and Children's Hospital, Singapore Singapore

241
Evaluation of Diesse Cube 30 Touch Erythrocyte Sedimentation Method with Alcor iSED ESR Analyser
H.J. Yeo, F. Ilagan, K.L. Cheng, V. Prasad. Khoo Teck Puat Hospital, Department of Laboratory Medicine, Singapore, Singapore

243
EFLM Biological Variation Estimates of Hematology Data Are Not Fit for Newer Purposes; Let’s Use Real Patient Data
George Cembrowski1, 2, Jialin Qiu1, Christopher McCudden3, 4. 1University of Alberta, Edmonton, AB, Canada.2CCQCC, Edmonton, AB, Canada.3University of Ottawa, Ottawa, ON, Canada.4Ottawa Hospital, Ottawa, ON, Canada

245
An Exploratory Quality Analysis of Bone Marrow Aspirate Derived Plasma Processing for Potential Future Clinical and Research Applications In Myeloid Neoplasms
Thibika Gunalingam1, 2, 3, Alexandra Misura1, 2, Katarina Czibere1, 2, Winston Ukpong1, 2, 3, Mira Jani1, 3, 4, Tina Khazaee1, 2, Paul Yip2, 5, Signy Chow6, 7Hubert Tsui1, 2, 5, 8, 9. 1Sunnybrook Biobank, Department of Laboratory Medicine and Molecular Diagnostics, Precision Diagnostics and Therapeutics Program, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.2Biological Sciences Platform, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.3Arts and Sciences Cooperative Program, University of Toronto a, Toronto, ON, Canada.4Evaluative Clinical Sciences, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.5Department of Laboratory Medicine and Pathobiology, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.6Hematology Site Group, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.7Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.8Division of Hematological Pathology, Department of Laboratory Medicine and Molecular Diagnostics, Precision Diagnostics and Therapeutics Program, Sunnybrook Health Sciences Centre and Sunnybrook Research Institute, Toronto, ON, Canada.9Department of Immunology, University of Toronto, Toronto, ON, Canada

249
Driving Excellence in Hematology Proficiency Testing: Insights from the 2024 Institute for Quality Management in Healthcare Customer Satisfaction Survey
Karen A Moffat1, 2Anna Johnston3, Sumedha Kulkarni3, Tess Koerner4, Brittnee V Ross3, Miranda Wozniak5, David Good6. 1Hamilton Regional Laboratory Medicine Program, Hamilton, ON, Canada.2Department of Medicine, McMaster University, Hamilton, ON, Canada.3Institute for Quality Management in Healthcare, Toronto, ON, Canada.4Accreditation Canada, Ottawa, ON, Canada.5Dynacare Medical Laboratories, Brampton, ON, Canada.6Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON, Canada

251
A Reference Range Interval Establishment in a Tertiary Teaching Hospital: Performance Evaluation on Mindray BC6200
Nurul Asyikin Nizam Akbar1, 2, Zefarina Zulkafli1, 2, Ahmad Sharifuddin Mukhtarruddin1, 2, Salfarina Iberahim 1, 2, Nur Ilyia Syazwani Saidin 1, 2, Rosnah Bahar 1, 2, Mohd Nazri Hassan1, 2, Marne Abdullah 1, 2, Razan Hayati Zulkeflee1, 2, Mohamad Nashrul Ghazali3, Muhammad Faiz Mohd Ismail 3. 1Department of Haematology a Transfusion Medicine Unit, School of Medical Sciences, Universiti Sains Malaysia (USM), Kota Bharu, Malaysia.2Hospital Pakar Universiti Sains Malaysia (HPUSM), Kota Bharu, Malaysia.3Utas Maju Sdn Bhd, Petaling Jaya, Malaysia

255
Accelerated Processes in Laboratory Hematology with Automation
Christopher Yu1, Habib M. Razavi2, 3, Majid Moteabbed2, 3, Richard Yu2. 1Faculty of Health Sciences, Western University, London, ON, Canada.2Division of Hematopathology and Transfusion Medicine, Fraser Health Authority, Surrey, BC, Canada.3Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada